loading

Eagle Pharmaceuticals Inc 주식(EGRX)의 최신 뉴스

pulisher
Feb 06, 2025

EGRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Eagle Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 06, 2025
pulisher
Feb 01, 2025

Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Feb 01, 2025
pulisher
Jan 26, 2025

Eagle Pharmaceuticals, Inc. Enters Third Amended and Restated Credit Agreement - Marketscreener.com

Jan 26, 2025
pulisher
Jan 24, 2025

StockNews.com Begins Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World

Jan 24, 2025
pulisher
Jan 16, 2025

Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated at StockNews.com - Defense World

Jan 16, 2025
pulisher
Jan 15, 2025

Jane Street Group LLC Makes New Investment in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World

Jan 15, 2025
pulisher
Jan 03, 2025

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09% - MSN

Jan 03, 2025
pulisher
Dec 30, 2024

Antiemetics Drugs Market Size & Share Report, 2024 – 2032 - Global Market Insights

Dec 30, 2024
pulisher
Dec 23, 2024

Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by StockNews.com - Defense World

Dec 23, 2024
pulisher
Dec 21, 2024

Last Week's Biggest Stock Movers: Eagle, Noodles & Co. - AOL

Dec 21, 2024
pulisher
Dec 12, 2024

Eagle Pharmaceuticals Enters Into Settlement Agreement With Dr. Reddy's Laboratories on Leukemia Drug - Marketscreener.com

Dec 12, 2024
pulisher
Dec 03, 2024

Eagle Pharmaceuticals : to Present at Jefferies Virtual Healthcare Conference 2021 - Marketscreener.com

Dec 03, 2024
pulisher
Dec 03, 2024

Eagle Pharmaceuticals Amends Rights Agreement with Equiniti Trust Company - Defense World

Dec 03, 2024
pulisher
Dec 02, 2024

Eagle Pharmaceuticals amends rights agreement - Investing.com

Dec 02, 2024
pulisher
Dec 02, 2024

Eagle Pharmaceuticals amends rights agreement By Investing.com - Investing.com Nigeria

Dec 02, 2024
pulisher
Nov 29, 2024

Eagle Pharmaceuticals Dismisses Ernst & Young LLP as Independent Registered Public Accounting Firm - Defense World

Nov 29, 2024
pulisher
Nov 27, 2024

Eagle Pharmaceuticals switches to BDO after Ernst & Young dismissal - Investing.com

Nov 27, 2024
pulisher
Nov 27, 2024

Eagle Pharmaceuticals switches to BDO after Ernst & Young dismissal By Investing.com - Investing.com UK

Nov 27, 2024
pulisher
Nov 25, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceutica - GuruFocus.com

Nov 25, 2024
pulisher
Nov 21, 2024

Eagle Pharma Founder Sues Company to Recoup Cost of SEC Investigation - Law.com

Nov 21, 2024
pulisher
Nov 20, 2024

Ex-Pharma CEO Demands Legal Fees For SEC Probe - Law360

Nov 20, 2024
pulisher
Nov 19, 2024

Eagle Pharmaceuticals names Christopher Krawtschuk as CFO - MSN

Nov 19, 2024
pulisher
Nov 17, 2024

Eagle Pharmaceuticals to Delist from Nasdaq By Investing.com - Investing.com Australia

Nov 17, 2024
pulisher
Nov 17, 2024

Eagle Pharmaceuticals, Inc. Announces Executive Changes - Marketscreener.com

Nov 17, 2024
pulisher
Nov 16, 2024

Eagle Pharmaceuticals to Delist from Nasdaq - Investing.com India

Nov 16, 2024
pulisher
Nov 16, 2024

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration - The Manila Times

Nov 16, 2024
pulisher
Nov 15, 2024

Eagle Pharmaceuticals to Complete Nasdaq Delisting After Trading Suspension | EGRX Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 13, 2024

Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com - Defense World

Nov 13, 2024
pulisher
Nov 13, 2024

Citigroup Inc's Strategic Reduction in Eagle Pharmaceuticals Inc Shares - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Creative Planning Makes New $59,000 Investment in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World

Nov 13, 2024
pulisher
Nov 13, 2024

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial OfficerWOODCLIFF LAKE, N.J. — November 12, 2024 — Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) recently announced the appointment of Christopher Krawtschuk as the Chief - Defense World

Nov 13, 2024
pulisher
Nov 12, 2024

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Eagle Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com

Nov 12, 2024
pulisher
Nov 08, 2024

Some Major Key Players In The Heparin-Induced Thrombocytopenia (HIT) Treatment Market: - InsightAce Analytic

Nov 08, 2024
pulisher
Nov 06, 2024

Nantahala Capital Management Reduces Stake in Eagle Pharmaceuticals - GuruFocus.com

Nov 06, 2024
pulisher
Nov 03, 2024

Eagle Pharmaceuticals to Develop Dantrolene Sodium for Potential Treatment of Alzheimer’S Disease in Collaboration with University of Pennsylvania - Marketscreener.com

Nov 03, 2024
pulisher
Nov 02, 2024

Eagle Pharmaceuticals Adopts Stockholder Rights Plan to Protect Shareholders’ Interests - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

Union Square Park Capital Management, LLC Increases Stake in Eagle Pharmaceuticals Inc - GuruFocus.com

Nov 01, 2024
pulisher
Oct 31, 2024

Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle - GlobeNewswire

Oct 31, 2024
pulisher
Oct 29, 2024

Pemetrexed Market Is Booming Worldwide 2024-2031 | Stada - openPR

Oct 29, 2024
pulisher
Oct 14, 2024

Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - ForexTV.com

Oct 14, 2024
pulisher
Oct 14, 2024

Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.

Oct 14, 2024
pulisher
Oct 12, 2024

Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by Analysts at StockNews.com - Defense World

Oct 12, 2024
pulisher
Oct 10, 2024

Global Antiemetics Drugs Market to Exhibit Growth at a CAGR of ~6% by 2030 | DelveInsight - GlobeNewswire

Oct 10, 2024
$31.57
price up icon 0.57%
$11.52
price down icon 3.76%
$88.71
price down icon 2.41%
$122.62
price down icon 18.53%
$10.73
price down icon 1.56%
$127.01
price down icon 0.09%
자본화:     |  볼륨(24시간):